Global AAV and Lentivirus Transfection Reagent Market Growth 2025-2031

March 2025 | 102 pages | ID: G833BE6D4868EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

The global AAV and Lentivirus Transfection Reagent market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

United States market for AAV and Lentivirus Transfection Reagent is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for AAV and Lentivirus Transfection Reagent is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for AAV and Lentivirus Transfection Reagent is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key AAV and Lentivirus Transfection Reagent players cover Thermo Fisher Scientific, Polyplus Transfection, Promega, SignaGen, Takara Bio, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “AAV and Lentivirus Transfection Reagent Industry Forecast” looks at past sales and reviews total world AAV and Lentivirus Transfection Reagent sales in 2024, providing a comprehensive analysis by region and market sector of projected AAV and Lentivirus Transfection Reagent sales for 2025 through 2031. With AAV and Lentivirus Transfection Reagent sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world AAV and Lentivirus Transfection Reagent industry.

This Insight Report provides a comprehensive analysis of the global AAV and Lentivirus Transfection Reagent landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on AAV and Lentivirus Transfection Reagent portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global AAV and Lentivirus Transfection Reagent market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for AAV and Lentivirus Transfection Reagent and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global AAV and Lentivirus Transfection Reagent.

This report presents a comprehensive overview, market shares, and growth opportunities of AAV and Lentivirus Transfection Reagent market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • Biochemical Transfection
  • Physical Transfection
Segmentation by Application:
  • Basic Research
  • Drug Research
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Thermo Fisher Scientific
  • Polyplus Transfection
  • Promega
  • SignaGen
  • Takara Bio
  • Bio-Rad Laboratories
  • Mirus Bio
Key Questions Addressed in this Report

What is the 10-year outlook for the global AAV and Lentivirus Transfection Reagent market?

What factors are driving AAV and Lentivirus Transfection Reagent market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do AAV and Lentivirus Transfection Reagent market opportunities vary by end market size?

How does AAV and Lentivirus Transfection Reagent break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global AAV and Lentivirus Transfection Reagent Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for AAV and Lentivirus Transfection Reagent by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for AAV and Lentivirus Transfection Reagent by Country/Region, 2020, 2024 & 2031
2.2 AAV and Lentivirus Transfection Reagent Segment by Type
  2.2.1 Biochemical Transfection
  2.2.2 Physical Transfection
2.3 AAV and Lentivirus Transfection Reagent Sales by Type
  2.3.1 Global AAV and Lentivirus Transfection Reagent Sales Market Share by Type (2020-2025)
  2.3.2 Global AAV and Lentivirus Transfection Reagent Revenue and Market Share by Type (2020-2025)
  2.3.3 Global AAV and Lentivirus Transfection Reagent Sale Price by Type (2020-2025)
2.4 AAV and Lentivirus Transfection Reagent Segment by Application
  2.4.1 Basic Research
  2.4.2 Drug Research
2.5 AAV and Lentivirus Transfection Reagent Sales by Application
  2.5.1 Global AAV and Lentivirus Transfection Reagent Sale Market Share by Application (2020-2025)
  2.5.2 Global AAV and Lentivirus Transfection Reagent Revenue and Market Share by Application (2020-2025)
  2.5.3 Global AAV and Lentivirus Transfection Reagent Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global AAV and Lentivirus Transfection Reagent Breakdown Data by Company
  3.1.1 Global AAV and Lentivirus Transfection Reagent Annual Sales by Company (2020-2025)
  3.1.2 Global AAV and Lentivirus Transfection Reagent Sales Market Share by Company (2020-2025)
3.2 Global AAV and Lentivirus Transfection Reagent Annual Revenue by Company (2020-2025)
  3.2.1 Global AAV and Lentivirus Transfection Reagent Revenue by Company (2020-2025)
  3.2.2 Global AAV and Lentivirus Transfection Reagent Revenue Market Share by Company (2020-2025)
3.3 Global AAV and Lentivirus Transfection Reagent Sale Price by Company
3.4 Key Manufacturers AAV and Lentivirus Transfection Reagent Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers AAV and Lentivirus Transfection Reagent Product Location Distribution
  3.4.2 Players AAV and Lentivirus Transfection Reagent Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR AAV AND LENTIVIRUS TRANSFECTION REAGENT BY GEOGRAPHIC REGION

4.1 World Historic AAV and Lentivirus Transfection Reagent Market Size by Geographic Region (2020-2025)
  4.1.1 Global AAV and Lentivirus Transfection Reagent Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global AAV and Lentivirus Transfection Reagent Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic AAV and Lentivirus Transfection Reagent Market Size by Country/Region (2020-2025)
  4.2.1 Global AAV and Lentivirus Transfection Reagent Annual Sales by Country/Region (2020-2025)
  4.2.2 Global AAV and Lentivirus Transfection Reagent Annual Revenue by Country/Region (2020-2025)
4.3 Americas AAV and Lentivirus Transfection Reagent Sales Growth
4.4 APAC AAV and Lentivirus Transfection Reagent Sales Growth
4.5 Europe AAV and Lentivirus Transfection Reagent Sales Growth
4.6 Middle East & Africa AAV and Lentivirus Transfection Reagent Sales Growth

5 AMERICAS

5.1 Americas AAV and Lentivirus Transfection Reagent Sales by Country
  5.1.1 Americas AAV and Lentivirus Transfection Reagent Sales by Country (2020-2025)
  5.1.2 Americas AAV and Lentivirus Transfection Reagent Revenue by Country (2020-2025)
5.2 Americas AAV and Lentivirus Transfection Reagent Sales by Type (2020-2025)
5.3 Americas AAV and Lentivirus Transfection Reagent Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC AAV and Lentivirus Transfection Reagent Sales by Region
  6.1.1 APAC AAV and Lentivirus Transfection Reagent Sales by Region (2020-2025)
  6.1.2 APAC AAV and Lentivirus Transfection Reagent Revenue by Region (2020-2025)
6.2 APAC AAV and Lentivirus Transfection Reagent Sales by Type (2020-2025)
6.3 APAC AAV and Lentivirus Transfection Reagent Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe AAV and Lentivirus Transfection Reagent by Country
  7.1.1 Europe AAV and Lentivirus Transfection Reagent Sales by Country (2020-2025)
  7.1.2 Europe AAV and Lentivirus Transfection Reagent Revenue by Country (2020-2025)
7.2 Europe AAV and Lentivirus Transfection Reagent Sales by Type (2020-2025)
7.3 Europe AAV and Lentivirus Transfection Reagent Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa AAV and Lentivirus Transfection Reagent by Country
  8.1.1 Middle East & Africa AAV and Lentivirus Transfection Reagent Sales by Country (2020-2025)
  8.1.2 Middle East & Africa AAV and Lentivirus Transfection Reagent Revenue by Country (2020-2025)
8.2 Middle East & Africa AAV and Lentivirus Transfection Reagent Sales by Type (2020-2025)
8.3 Middle East & Africa AAV and Lentivirus Transfection Reagent Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of AAV and Lentivirus Transfection Reagent
10.3 Manufacturing Process Analysis of AAV and Lentivirus Transfection Reagent
10.4 Industry Chain Structure of AAV and Lentivirus Transfection Reagent

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 AAV and Lentivirus Transfection Reagent Distributors
11.3 AAV and Lentivirus Transfection Reagent Customer

12 WORLD FORECAST REVIEW FOR AAV AND LENTIVIRUS TRANSFECTION REAGENT BY GEOGRAPHIC REGION

12.1 Global AAV and Lentivirus Transfection Reagent Market Size Forecast by Region
  12.1.1 Global AAV and Lentivirus Transfection Reagent Forecast by Region (2026-2031)
  12.1.2 Global AAV and Lentivirus Transfection Reagent Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global AAV and Lentivirus Transfection Reagent Forecast by Type (2026-2031)
12.7 Global AAV and Lentivirus Transfection Reagent Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Thermo Fisher Scientific
  13.1.1 Thermo Fisher Scientific Company Information
  13.1.2 Thermo Fisher Scientific AAV and Lentivirus Transfection Reagent Product Portfolios and Specifications
  13.1.3 Thermo Fisher Scientific AAV and Lentivirus Transfection Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Thermo Fisher Scientific Main Business Overview
  13.1.5 Thermo Fisher Scientific Latest Developments
13.2 Polyplus Transfection
  13.2.1 Polyplus Transfection Company Information
  13.2.2 Polyplus Transfection AAV and Lentivirus Transfection Reagent Product Portfolios and Specifications
  13.2.3 Polyplus Transfection AAV and Lentivirus Transfection Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Polyplus Transfection Main Business Overview
  13.2.5 Polyplus Transfection Latest Developments
13.3 Promega
  13.3.1 Promega Company Information
  13.3.2 Promega AAV and Lentivirus Transfection Reagent Product Portfolios and Specifications
  13.3.3 Promega AAV and Lentivirus Transfection Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Promega Main Business Overview
  13.3.5 Promega Latest Developments
13.4 SignaGen
  13.4.1 SignaGen Company Information
  13.4.2 SignaGen AAV and Lentivirus Transfection Reagent Product Portfolios and Specifications
  13.4.3 SignaGen AAV and Lentivirus Transfection Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 SignaGen Main Business Overview
  13.4.5 SignaGen Latest Developments
13.5 Takara Bio
  13.5.1 Takara Bio Company Information
  13.5.2 Takara Bio AAV and Lentivirus Transfection Reagent Product Portfolios and Specifications
  13.5.3 Takara Bio AAV and Lentivirus Transfection Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Takara Bio Main Business Overview
  13.5.5 Takara Bio Latest Developments
13.6 Bio-Rad Laboratories
  13.6.1 Bio-Rad Laboratories Company Information
  13.6.2 Bio-Rad Laboratories AAV and Lentivirus Transfection Reagent Product Portfolios and Specifications
  13.6.3 Bio-Rad Laboratories AAV and Lentivirus Transfection Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Bio-Rad Laboratories Main Business Overview
  13.6.5 Bio-Rad Laboratories Latest Developments
13.7 Mirus Bio
  13.7.1 Mirus Bio Company Information
  13.7.2 Mirus Bio AAV and Lentivirus Transfection Reagent Product Portfolios and Specifications
  13.7.3 Mirus Bio AAV and Lentivirus Transfection Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Mirus Bio Main Business Overview
  13.7.5 Mirus Bio Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION


LIST OFTABLES

Table 1. AAV and LentivirusTransfection Reagent Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. AAV and LentivirusTransfection Reagent Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of BiochemicalTransfection
Table 4. Major Players of PhysicalTransfection
Table 5. Global AAV and LentivirusTransfection Reagent Sales byType (2020-2025) & (K Units)
Table 6. Global AAV and LentivirusTransfection Reagent Sales Market Share byType (2020-2025)
Table 7. Global AAV and LentivirusTransfection Reagent Revenue byType (2020-2025) & ($ million)
Table 8. Global AAV and LentivirusTransfection Reagent Revenue Market Share byType (2020-2025)
Table 9. Global AAV and LentivirusTransfection Reagent Sale Price byType (2020-2025) & (US$/Unit)
Table 10. Global AAV and LentivirusTransfection Reagent Sale by Application (2020-2025) & (K Units)
Table 11. Global AAV and LentivirusTransfection Reagent Sale Market Share by Application (2020-2025)
Table 12. Global AAV and LentivirusTransfection Reagent Revenue by Application (2020-2025) & ($ million)
Table 13. Global AAV and LentivirusTransfection Reagent Revenue Market Share by Application (2020-2025)
Table 14. Global AAV and LentivirusTransfection Reagent Sale Price by Application (2020-2025) & (US$/Unit)
Table 15. Global AAV and LentivirusTransfection Reagent Sales by Company (2020-2025) & (K Units)
Table 16. Global AAV and LentivirusTransfection Reagent Sales Market Share by Company (2020-2025)
Table 17. Global AAV and LentivirusTransfection Reagent Revenue by Company (2020-2025) & ($ millions)
Table 18. Global AAV and LentivirusTransfection Reagent Revenue Market Share by Company (2020-2025)
Table 19. Global AAV and LentivirusTransfection Reagent Sale Price by Company (2020-2025) & (US$/Unit)
Table 20. Key Manufacturers AAV and LentivirusTransfection Reagent Producing Area Distribution and Sales Area
Table 21. Players AAV and LentivirusTransfection Reagent Products Offered
Table 22. AAV and LentivirusTransfection Reagent Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global AAV and LentivirusTransfection Reagent Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global AAV and LentivirusTransfection Reagent Sales Market Share Geographic Region (2020-2025)
Table 27. Global AAV and LentivirusTransfection Reagent Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global AAV and LentivirusTransfection Reagent Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global AAV and LentivirusTransfection Reagent Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global AAV and LentivirusTransfection Reagent Sales Market Share by Country/Region (2020-2025)
Table 31. Global AAV and LentivirusTransfection Reagent Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global AAV and LentivirusTransfection Reagent Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas AAV and LentivirusTransfection Reagent Sales by Country (2020-2025) & (K Units)
Table 34. Americas AAV and LentivirusTransfection Reagent Sales Market Share by Country (2020-2025)
Table 35. Americas AAV and LentivirusTransfection Reagent Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas AAV and LentivirusTransfection Reagent Sales byType (2020-2025) & (K Units)
Table 37. Americas AAV and LentivirusTransfection Reagent Sales by Application (2020-2025) & (K Units)
Table 38. APAC AAV and LentivirusTransfection Reagent Sales by Region (2020-2025) & (K Units)
Table 39. APAC AAV and LentivirusTransfection Reagent Sales Market Share by Region (2020-2025)
Table 40. APAC AAV and LentivirusTransfection Reagent Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC AAV and LentivirusTransfection Reagent Sales byType (2020-2025) & (K Units)
Table 42. APAC AAV and LentivirusTransfection Reagent Sales by Application (2020-2025) & (K Units)
Table 43. Europe AAV and LentivirusTransfection Reagent Sales by Country (2020-2025) & (K Units)
Table 44. Europe AAV and LentivirusTransfection Reagent Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe AAV and LentivirusTransfection Reagent Sales byType (2020-2025) & (K Units)
Table 46. Europe AAV and LentivirusTransfection Reagent Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa AAV and LentivirusTransfection Reagent Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa AAV and LentivirusTransfection Reagent Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa AAV and LentivirusTransfection Reagent Sales byType (2020-2025) & (K Units)
Table 50. Middle East & Africa AAV and LentivirusTransfection Reagent Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of AAV and LentivirusTransfection Reagent
Table 52. Key Market Challenges & Risks of AAV and LentivirusTransfection Reagent
Table 53. Key IndustryTrends of AAV and LentivirusTransfection Reagent
Table 54. AAV and LentivirusTransfection Reagent Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. AAV and LentivirusTransfection Reagent Distributors List
Table 57. AAV and LentivirusTransfection Reagent Customer List
Table 58. Global AAV and LentivirusTransfection Reagent SalesForecast by Region (2026-2031) & (K Units)
Table 59. Global AAV and LentivirusTransfection Reagent RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas AAV and LentivirusTransfection Reagent SalesForecast by Country (2026-2031) & (K Units)
Table 61. Americas AAV and LentivirusTransfection Reagent Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC AAV and LentivirusTransfection Reagent SalesForecast by Region (2026-2031) & (K Units)
Table 63. APAC AAV and LentivirusTransfection Reagent Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe AAV and LentivirusTransfection Reagent SalesForecast by Country (2026-2031) & (K Units)
Table 65. Europe AAV and LentivirusTransfection Reagent RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa AAV and LentivirusTransfection Reagent SalesForecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa AAV and LentivirusTransfection Reagent RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global AAV and LentivirusTransfection Reagent SalesForecast byType (2026-2031) & (K Units)
Table 69. Global AAV and LentivirusTransfection Reagent RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global AAV and LentivirusTransfection Reagent SalesForecast by Application (2026-2031) & (K Units)
Table 71. Global AAV and LentivirusTransfection Reagent RevenueForecast by Application (2026-2031) & ($ millions)
Table 72.ThermoFisher Scientific Basic Information, AAV and LentivirusTransfection Reagent Manufacturing Base, Sales Area and Its Competitors
Table 73.ThermoFisher Scientific AAV and LentivirusTransfection Reagent Product Portfolios and Specifications
Table 74.ThermoFisher Scientific AAV and LentivirusTransfection Reagent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75.ThermoFisher Scientific Main Business
Table 76.ThermoFisher Scientific Latest Developments
Table 77. PolyplusTransfection Basic Information, AAV and LentivirusTransfection Reagent Manufacturing Base, Sales Area and Its Competitors
Table 78. PolyplusTransfection AAV and LentivirusTransfection Reagent Product Portfolios and Specifications
Table 79. PolyplusTransfection AAV and LentivirusTransfection Reagent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. PolyplusTransfection Main Business
Table 81. PolyplusTransfection Latest Developments
Table 82. Promega Basic Information, AAV and LentivirusTransfection Reagent Manufacturing Base, Sales Area and Its Competitors
Table 83. Promega AAV and LentivirusTransfection Reagent Product Portfolios and Specifications
Table 84. Promega AAV and LentivirusTransfection Reagent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Promega Main Business
Table 86. Promega Latest Developments
Table 87. SignaGen Basic Information, AAV and LentivirusTransfection Reagent Manufacturing Base, Sales Area and Its Competitors
Table 88. SignaGen AAV and LentivirusTransfection Reagent Product Portfolios and Specifications
Table 89. SignaGen AAV and LentivirusTransfection Reagent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. SignaGen Main Business
Table 91. SignaGen Latest Developments
Table 92.Takara Bio Basic Information, AAV and LentivirusTransfection Reagent Manufacturing Base, Sales Area and Its Competitors
Table 93.Takara Bio AAV and LentivirusTransfection Reagent Product Portfolios and Specifications
Table 94.Takara Bio AAV and LentivirusTransfection Reagent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95.Takara Bio Main Business
Table 96.Takara Bio Latest Developments
Table 97. Bio-Rad Laboratories Basic Information, AAV and LentivirusTransfection Reagent Manufacturing Base, Sales Area and Its Competitors
Table 98. Bio-Rad Laboratories AAV and LentivirusTransfection Reagent Product Portfolios and Specifications
Table 99. Bio-Rad Laboratories AAV and LentivirusTransfection Reagent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Bio-Rad Laboratories Main Business
Table 101. Bio-Rad Laboratories Latest Developments
Table 102. Mirus Bio Basic Information, AAV and LentivirusTransfection Reagent Manufacturing Base, Sales Area and Its Competitors
Table 103. Mirus Bio AAV and LentivirusTransfection Reagent Product Portfolios and Specifications
Table 104. Mirus Bio AAV and LentivirusTransfection Reagent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. Mirus Bio Main Business
Table 106. Mirus Bio Latest Developments



LIST OFFIGURES

Figure 1. Picture of AAV and LentivirusTransfection Reagent
Figure 2. AAV and LentivirusTransfection Reagent Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global AAV and LentivirusTransfection Reagent Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global AAV and LentivirusTransfection Reagent Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. AAV and LentivirusTransfection Reagent Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. AAV and LentivirusTransfection Reagent Sales Market Share by Country/Region (2024)
Figure 10. AAV and LentivirusTransfection Reagent Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of BiochemicalTransfection
Figure 12. Product Picture of PhysicalTransfection
Figure 13. Global AAV and LentivirusTransfection Reagent Sales Market Share byType in 2025
Figure 14. Global AAV and LentivirusTransfection Reagent Revenue Market Share byType (2020-2025)
Figure 15. AAV and LentivirusTransfection Reagent Consumed in Basic Research
Figure 16. Global AAV and LentivirusTransfection Reagent Market: Basic Research (2020-2025) & (K Units)
Figure 17. AAV and LentivirusTransfection Reagent Consumed in Drug Research
Figure 18. Global AAV and LentivirusTransfection Reagent Market: Drug Research (2020-2025) & (K Units)
Figure 19. Global AAV and LentivirusTransfection Reagent Sale Market Share by Application (2024)
Figure 20. Global AAV and LentivirusTransfection Reagent Revenue Market Share by Application in 2025
Figure 21. AAV and LentivirusTransfection Reagent Sales by Company in 2025 (K Units)
Figure 22. Global AAV and LentivirusTransfection Reagent Sales Market Share by Company in 2025
Figure 23. AAV and LentivirusTransfection Reagent Revenue by Company in 2025 ($ millions)
Figure 24. Global AAV and LentivirusTransfection Reagent Revenue Market Share by Company in 2025
Figure 25. Global AAV and LentivirusTransfection Reagent Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global AAV and LentivirusTransfection Reagent Revenue Market Share by Geographic Region in 2025
Figure 27. Americas AAV and LentivirusTransfection Reagent Sales 2020-2025 (K Units)
Figure 28. Americas AAV and LentivirusTransfection Reagent Revenue 2020-2025 ($ millions)
Figure 29. APAC AAV and LentivirusTransfection Reagent Sales 2020-2025 (K Units)
Figure 30. APAC AAV and LentivirusTransfection Reagent Revenue 2020-2025 ($ millions)
Figure 31. Europe AAV and LentivirusTransfection Reagent Sales 2020-2025 (K Units)
Figure 32. Europe AAV and LentivirusTransfection Reagent Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa AAV and LentivirusTransfection Reagent Sales 2020-2025 (K Units)
Figure 34. Middle East & Africa AAV and LentivirusTransfection Reagent Revenue 2020-2025 ($ millions)
Figure 35. Americas AAV and LentivirusTransfection Reagent Sales Market Share by Country in 2025
Figure 36. Americas AAV and LentivirusTransfection Reagent Revenue Market Share by Country (2020-2025)
Figure 37. Americas AAV and LentivirusTransfection Reagent Sales Market Share byType (2020-2025)
Figure 38. Americas AAV and LentivirusTransfection Reagent Sales Market Share by Application (2020-2025)
Figure 39. United States AAV and LentivirusTransfection Reagent Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada AAV and LentivirusTransfection Reagent Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico AAV and LentivirusTransfection Reagent Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil AAV and LentivirusTransfection Reagent Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC AAV and LentivirusTransfection Reagent Sales Market Share by Region in 2025
Figure 44. APAC AAV and LentivirusTransfection Reagent Revenue Market Share by Region (2020-2025)
Figure 45. APAC AAV and LentivirusTransfection Reagent Sales Market Share byType (2020-2025)
Figure 46. APAC AAV and LentivirusTransfection Reagent Sales Market Share by Application (2020-2025)
Figure 47. China AAV and LentivirusTransfection Reagent Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan AAV and LentivirusTransfection Reagent Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea AAV and LentivirusTransfection Reagent Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia AAV and LentivirusTransfection Reagent Revenue Growth 2020-2025 ($ millions)
Figure 51. India AAV and LentivirusTransfection Reagent Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia AAV and LentivirusTransfection Reagent Revenue Growth 2020-2025 ($ millions)
Figure 53. ChinaTaiwan AAV and LentivirusTransfection Reagent Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe AAV and LentivirusTransfection Reagent Sales Market Share by Country in 2025
Figure 55. Europe AAV and LentivirusTransfection Reagent Revenue Market Share by Country (2020-2025)
Figure 56. Europe AAV and LentivirusTransfection Reagent Sales Market Share byType (2020-2025)
Figure 57. Europe AAV and LentivirusTransfection Reagent Sales Market Share by Application (2020-2025)
Figure 58. Germany AAV and LentivirusTransfection Reagent Revenue Growth 2020-2025 ($ millions)
Figure 59.France AAV and LentivirusTransfection Reagent Revenue Growth 2020-2025 ($ millions)
Figure 60. UK AAV and LentivirusTransfection Reagent Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy AAV and LentivirusTransfection Reagent Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia AAV and LentivirusTransfection Reagent Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa AAV and LentivirusTransfection Reagent Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa AAV and LentivirusTransfection Reagent Sales Market Share byType (2020-2025)
Figure 65. Middle East & Africa AAV and LentivirusTransfection Reagent Sales Market Share by Application (2020-2025)
Figure 66. Egypt AAV and LentivirusTransfection Reagent Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa AAV and LentivirusTransfection Reagent Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel AAV and LentivirusTransfection Reagent Revenue Growth 2020-2025 ($ millions)
Figure 69.Turkey AAV and LentivirusTransfection Reagent Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries AAV and LentivirusTransfection Reagent Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of AAV and LentivirusTransfection Reagent in 2025
Figure 72. Manufacturing Process Analysis of AAV and LentivirusTransfection Reagent
Figure 73. Industry Chain Structure of AAV and LentivirusTransfection Reagent
Figure 74. Channels of Distribution
Figure 75. Global AAV and LentivirusTransfection Reagent Sales MarketForecast by Region (2026-2031)
Figure 76. Global AAV and LentivirusTransfection Reagent Revenue Market ShareForecast by Region (2026-2031)
Figure 77. Global AAV and LentivirusTransfection Reagent Sales Market ShareForecast byType (2026-2031)
Figure 78. Global AAV and LentivirusTransfection Reagent Revenue Market ShareForecast byType (2026-2031)
Figure 79. Global AAV and LentivirusTransfection Reagent Sales Market ShareForecast by Application (2026-2031)
Figure 80. Global AAV and LentivirusTransfection Reagent Revenue Market ShareForecast by Application (2026-2031)